● 장전 상황
Stock futures moved lower in premarket trading Friday as investors braced for the final trading day of the worst year for stocks since 2008.
Futures tied to the Dow Jones Industrial Average slipped 153 points, or 0.5%. S&P 500 and Nasdaq 100 futures traded lower by 0.7% and 1.1%, respectively.
The overnight moves followed a rally Thursday, with the Nasdaq Composite and S&P 500 climbing about 2.6% and roughly 1.8%, respectively. The Dow jumped 345 points, or 1.05%.
For the week, the Dow and S&P are slightly higher, with the Nasdaq on track for a modest loss. All major averages are lower for December and are poised to snap a two-month win streak.
● 미국채 수익률
● 기업단신
Li Auto (LI) – Li Auto said it expected to deliver more than 20,000 of its electric vehicles this month, higher than the 14,087 the China-based EV maker delivered in December 2021.
Southwest Airlines (LUV) – Southwest said it planned to return to a regular flight schedule Friday and promised to reimburse customers for any reasonable expenses they incurred due to the airline canceling thousands of flights over the past week.
Tesla (TSLA) – Tesla is down 1% in the premarket after posting its first back-to-back gains since November 22 to 23. Tesla has not risen three days in a row since a four-day win streak from October 25 to 28. The stock is still down 65% for 2022.
Audacy (AUD) – Audacy stock rallied 9.7% in the premarket after the small-cap radio station operator said it will auction off the radio.com internet domain with a reported minimum bid of $2.5 million.
Mesa Air Group (MESA) – The regional air carrier reported a bigger-than-expected quarterly loss and revenue that fell short of analyst estimates. Mesa shares fell 3% in premarket trading.
Enovix (ENVX) – The lithium-ion battery manufacturer appointed Raj Talluri as its chief executive officer, effective January 18. Talluri was senior vice president and general manager of Micron Technology’s (MU) mobile business unit. Enovix jumped 5.1% in premarket action.
● New Covid pill shows promise
A trial in China showed that VV116, an experimental antiviral drug for treating Covid, was just as effective as Pfizer’s Paxlovid in limiting illness in people at high risk for severe disease. The findings also indicated that the new pill could have fewer side effects that Paxlovid. VV116, made by Junshi Biosciences and Vigonvita Life Science, is similar to remdesivir, which is approved as an IV infusion, but the new drug comes in pill form. The news about VV116 comes as China confronts a surge in coronavirus infections after Xi Jinping’s government abruptly ended its zero Covid policy.
* 필자의 생각: 내가 중국 확진자 폭등할꺼라 햇째? 근데 팍스로비드랑 렘데시비르랑 비슷…? 왠지 찜찜…
● The end of zero-covid pushed China’s biggest funeral services stock up by 80%
Fu Shou Yuan is China’s largest provider of funeral and burial services. It’s been in operation since 1994, working in 16 cities in 10 provinces. It owns 14 cemeteries and manages three.
The company’s stock, which is traded in Hong Kong, has been surging for the past two months. It has risen 80%, from HK$3.89 (US $0.50) on Oct. 31—its low for the year—to HK$7.04 (US $0.90) on Dec. 27.
The stock has gained significant traction especially in the past few days: It went up by 22% on Dec. 23, and then again by 10% on Dec. 27. The prices are still below the historic heights reached in 2020 and 2021 in connection with previous covid waves, when the stock was trading above HK$8.
Government sources say there have been 250 million covid cases, equal to 18% of the population, with the number of new cases up to 37 million a day. But China reported only one covid death for Dec. 26, while estimates put the real toll around 5,000 per 1 million infections.
● Lost in space
For an industry that’s inherently optimistic, 2022 offered little hope for several space companies that went public through so-called blank-check companies. Seven of them have been trading under $2 a share, and some broke the buck. There were some bright spots, though. Iridium, for instance, is up more than 20%. Investors should expect more space mergers and acquisitions in 2023, while several companies could simply cease to exist, according to CNBC space reporter Michael Sheetz.
